Invention Grant
- Patent Title: Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof
-
Application No.: US16569578Application Date: 2019-09-12
-
Publication No.: US11053199B2Publication Date: 2021-07-06
- Inventor: Lianfeng Huang , Nancy Tsou , Nicole Suzanne White , Jun Xu , Qun Zhang
- Applicant: Celgene Corporation , Abide Therapeutics, Inc.
- Applicant Address: US NJ Summit; US CA San Diego
- Assignee: Celgene Corporation,Abide Therapeutics, Inc.
- Current Assignee: Celgene Corporation,Abide Therapeutics, Inc.
- Current Assignee Address: US NJ Summit; US CA San Diego
- Agency: Jones Day
- Main IPC: C07D211/94
- IPC: C07D211/94 ; A61P35/00
Abstract:
Provided herein are crystalline forms of (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate. Pharmaceutical compositions comprising crystalline forms of (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate are also disclosed.
Public/Granted literature
Information query
